Pub Date : 2013-04-01DOI: 10.1007/s11789-013-0055-0
U. Ravens
{"title":"Medikamentöse Therapie bei Frauen – Was gilt es zu beachten?","authors":"U. Ravens","doi":"10.1007/s11789-013-0055-0","DOIUrl":"https://doi.org/10.1007/s11789-013-0055-0","url":null,"abstract":"","PeriodicalId":39208,"journal":{"name":"Clinical Research in Cardiology Supplements","volume":"8 1","pages":"32-37"},"PeriodicalIF":0.0,"publicationDate":"2013-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11789-013-0055-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"52661728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2013-04-01DOI: 10.1007/s11789-013-0058-x
P. Ong, A. Athanasiadis, U. Sechtem
{"title":"Gender aspects in patients with angina and unobstructed coronary arteries","authors":"P. Ong, A. Athanasiadis, U. Sechtem","doi":"10.1007/s11789-013-0058-x","DOIUrl":"https://doi.org/10.1007/s11789-013-0058-x","url":null,"abstract":"","PeriodicalId":39208,"journal":{"name":"Clinical Research in Cardiology Supplements","volume":"51 1","pages":"25-31"},"PeriodicalIF":0.0,"publicationDate":"2013-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11789-013-0058-x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"52661840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2013-04-01DOI: 10.1007/s11789-013-0056-z
U. Seeland, V. Regitz-Zagrosek
{"title":"Genes and hormones: sex differences in myocardial hypertrophy","authors":"U. Seeland, V. Regitz-Zagrosek","doi":"10.1007/s11789-013-0056-z","DOIUrl":"https://doi.org/10.1007/s11789-013-0056-z","url":null,"abstract":"","PeriodicalId":39208,"journal":{"name":"Clinical Research in Cardiology Supplements","volume":"8 1","pages":"6-13"},"PeriodicalIF":0.0,"publicationDate":"2013-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11789-013-0056-z","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"52661759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2013-04-01DOI: 10.1007/s11789-013-0057-y
Alexandra Boese, C. Herrmann-Lingen
{"title":"Der feine Unterschied – Genderspezifische Aspekte psychosozialer Risikofaktoren und Interventionen bei Patienten mit koronarer Herzkrankheit","authors":"Alexandra Boese, C. Herrmann-Lingen","doi":"10.1007/s11789-013-0057-y","DOIUrl":"https://doi.org/10.1007/s11789-013-0057-y","url":null,"abstract":"","PeriodicalId":39208,"journal":{"name":"Clinical Research in Cardiology Supplements","volume":"8 1","pages":"46-51"},"PeriodicalIF":0.0,"publicationDate":"2013-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11789-013-0057-y","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"52661810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2013-04-01DOI: 10.1007/s11789-013-0051-4
S. Apostolakis, S. Konstantinides
{"title":"Gender and the risk of stroke in atrial fibrillation: impact of old and new anticoagulation regimens","authors":"S. Apostolakis, S. Konstantinides","doi":"10.1007/s11789-013-0051-4","DOIUrl":"https://doi.org/10.1007/s11789-013-0051-4","url":null,"abstract":"","PeriodicalId":39208,"journal":{"name":"Clinical Research in Cardiology Supplements","volume":"8 1","pages":"38-45"},"PeriodicalIF":0.0,"publicationDate":"2013-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11789-013-0051-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"52662092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2013-04-01DOI: 10.1007/s11789-013-0052-3
J. Mehilli, Lamin A. King
{"title":"Risk-treatment paradox in women with symptomatic coronary artery disease","authors":"J. Mehilli, Lamin A. King","doi":"10.1007/s11789-013-0052-3","DOIUrl":"https://doi.org/10.1007/s11789-013-0052-3","url":null,"abstract":"","PeriodicalId":39208,"journal":{"name":"Clinical Research in Cardiology Supplements","volume":"117 1","pages":"20-24"},"PeriodicalIF":0.0,"publicationDate":"2013-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11789-013-0052-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"52662121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2013-04-01DOI: 10.1007/s11789-013-0054-1
K. Odening, M. Zehender, C. Bode, M. Brunner
{"title":"Sex differences and sex hormone effects in long-QT syndrome: what can we learn from rabbit models?","authors":"K. Odening, M. Zehender, C. Bode, M. Brunner","doi":"10.1007/s11789-013-0054-1","DOIUrl":"https://doi.org/10.1007/s11789-013-0054-1","url":null,"abstract":"","PeriodicalId":39208,"journal":{"name":"Clinical Research in Cardiology Supplements","volume":"8 1","pages":"14-19"},"PeriodicalIF":0.0,"publicationDate":"2013-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11789-013-0054-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"52661684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2013-04-01DOI: 10.1007/s11789-013-0053-2
O. Mittag
{"title":"Genderspezifische Aspekte in der Sekundärprävention der koronaren Herzerkrankung","authors":"O. Mittag","doi":"10.1007/s11789-013-0053-2","DOIUrl":"https://doi.org/10.1007/s11789-013-0053-2","url":null,"abstract":"","PeriodicalId":39208,"journal":{"name":"Clinical Research in Cardiology Supplements","volume":"79 1","pages":"52-56"},"PeriodicalIF":0.0,"publicationDate":"2013-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11789-013-0053-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"52662149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2012-06-01DOI: 10.1007/s11789-012-0047-5
Peter Grützmacher, Claudius Kleinert
For long-term lipid apheresis therapy, several different technical systems have been developed which enable effective reduction of LDL cholesterol and other atherogenic lipoproteins, such as Lp(a), with sufficient selectivity and good clinical tolerance. Suitable techniques include whole blood adsorption with polyacrylamide and dextran sulfate cellulose, while primary plasma separation is used for cascade filtration, heparin-induced precipitation, immunoadsorption, silicate gel adsorption, and dextran sulfate cellulose (both techniques). The technical features are described. Only intensive training and experience of the medical personnel guarantees reliable treatment safety of all systems at a very low rate of minor side effects.
{"title":"Lipid apheresis techniques: current status in Germany.","authors":"Peter Grützmacher, Claudius Kleinert","doi":"10.1007/s11789-012-0047-5","DOIUrl":"https://doi.org/10.1007/s11789-012-0047-5","url":null,"abstract":"<p><p>For long-term lipid apheresis therapy, several different technical systems have been developed which enable effective reduction of LDL cholesterol and other atherogenic lipoproteins, such as Lp(a), with sufficient selectivity and good clinical tolerance. Suitable techniques include whole blood adsorption with polyacrylamide and dextran sulfate cellulose, while primary plasma separation is used for cascade filtration, heparin-induced precipitation, immunoadsorption, silicate gel adsorption, and dextran sulfate cellulose (both techniques). The technical features are described. Only intensive training and experience of the medical personnel guarantees reliable treatment safety of all systems at a very low rate of minor side effects.</p>","PeriodicalId":39208,"journal":{"name":"Clinical Research in Cardiology Supplements","volume":"7 ","pages":"20-3"},"PeriodicalIF":0.0,"publicationDate":"2012-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11789-012-0047-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30849427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2012-06-01DOI: 10.1007/s11789-012-0044-8
Martin Canis, Franz Heigl, Markus Suckfuell
Background: Fibrinogen/LDL apheresis has been proven to be effective in treatment of sudden sensorineural hearing loss (SSNH). This study is aimed to investigate if reduction of fibrinogen and serum LDL is also effective in patients with SSNH non-responding toward treatment with corticosteroids and plasmaexpanders.
Methods: Remission rates of 217 patients suffering from SSHL were investigated after treatment with apheresis. All patients were non-responders after other therapies such as high doses of steroids or plasmaexpanders.
Results: Single apheresis resulted in complete or partial remissions in 61% of patients when given after other unsuccessful conducted therapies such as corticosteroids and plasmaexpanders.
Conclusion: Fibrinogen/LDL apheresis is a promising rescue therapy for sudden sensorineural hearing loss even after unsuccessful other therapies.
{"title":"Fibrinogen/LDL apheresis is a promising rescue therapy for sudden sensorineural hearing loss.","authors":"Martin Canis, Franz Heigl, Markus Suckfuell","doi":"10.1007/s11789-012-0044-8","DOIUrl":"https://doi.org/10.1007/s11789-012-0044-8","url":null,"abstract":"<p><strong>Background: </strong>Fibrinogen/LDL apheresis has been proven to be effective in treatment of sudden sensorineural hearing loss (SSNH). This study is aimed to investigate if reduction of fibrinogen and serum LDL is also effective in patients with SSNH non-responding toward treatment with corticosteroids and plasmaexpanders.</p><p><strong>Methods: </strong>Remission rates of 217 patients suffering from SSHL were investigated after treatment with apheresis. All patients were non-responders after other therapies such as high doses of steroids or plasmaexpanders.</p><p><strong>Results: </strong>Single apheresis resulted in complete or partial remissions in 61% of patients when given after other unsuccessful conducted therapies such as corticosteroids and plasmaexpanders.</p><p><strong>Conclusion: </strong>Fibrinogen/LDL apheresis is a promising rescue therapy for sudden sensorineural hearing loss even after unsuccessful other therapies.</p>","PeriodicalId":39208,"journal":{"name":"Clinical Research in Cardiology Supplements","volume":" ","pages":"36-40"},"PeriodicalIF":0.0,"publicationDate":"2012-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/s11789-012-0044-8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40177134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}